Discontinuation report DOXORUBICIN

Last updated on 2021-08-25 History
Report ID 144561
Drug Identification Number 02410397
Brand name DOXORUBICIN
Common or Proper name DOXORUBICIN
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) DOXORUBICIN HYDROCHLORIDE
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVESICAL INTRAVENOUS INTRAVESICAL INTRAVENOUS
Packaging size 100mL
ATC code L01DB
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-08-24
Remaining supply date 2021-08-24
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2021-08-25 English Compare
v2 2021-08-24 French Compare
v1 2021-08-24 English Compare